X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Biopharmaceutical manufacturing companies continue to expand their economic footprint across the United States

By Tim McClung  |    May 24, 2023
Before 2020, the importance of robust and resilient supply chains and how they can affect access to life-saving treatments probably wasn’t top of mind for many outside the biopharmaceutical industry....   Read More

New Data: COVID-19 vaccine global production capacity projected to exceed 20 billion doses this year

By Megan Van Etten  |    February 24, 2022
Biopharmaceutical companies are working across the industry and around the world to meet the global demand for COVID-19 vaccines. Companies have continued to ramp up their efforts to source needed...   Read More

New report highlights importance of IP-intensive manufacturing industries to the U.S. economy

By Tim McClung  |    November 1, 2021
A new report from NDP Analytics showcases how innovation is the lifeblood of economic growth in the United States and that intellectual property (IP) protections are a crucial driver for high rates...   Read More

Intellectual property is the key to vaccine development, manufacturing and technology sharing

By Megan Van Etten  |    March 5, 2021
Earlier today, 31 PhRMA board members signed a letter to President Joe Biden applauding the Administration’s accelerating COVID-19 vaccine rollout, but also warning against efforts to undermine...   Read More

How industry collaboration and partnerships are supporting COVID-19 vaccine manufacturing

By Richard Moscicki, M.D.  |    March 4, 2021
Across the industry, biopharmaceutical companies are working around the clock to meet the demands of COVID-19 vaccine manufacturing. Companies are working to source needed raw materials and other...   Read More

American biopharmaceutical manufacturing: Fueling economic growth now and for years to come

By Nicole Longo  |    December 21, 2020
As the world has grappled with the current pandemic, there has been increased focus on biopharmaceutical manufacturing and its global supply chain. Many wondered whether the biopharmaceutical...   Read More

Manufacturing Day 2020: A closer look at the biopharmaceutical industry’s contributions

By Megan Van Etten  |    October 2, 2020
The first Friday of October marks Manufacturing Day, an annual recognition of the critical role manufacturing industries play in powering innovation and generating jobs and economic growth for...   Read More

Guest Post: How proactivity and planning helped Novartis ensure a stable supply of medicines during COVID-19

By Guest Contributor  |    September 16, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

By the numbers: A look at the sourcing of API used in medicines consumed in the United States

By Nicole Longo  |    July 16, 2020
There has been a lot of focus of late on where active pharmaceutical ingredients (APIs) for medicines are manufactured. While some may claim we are reliant on other countries, putting us at risk of...   Read More

Stakeholders raise concerns with proposed drastic changes to the pharmaceutical supply chain

By Nicole Longo  |    June 11, 2020
As we work to combat the current global pandemic, it is especially critical to maintain the stability of our global manufacturing supply chain. Unfortunately, recent policy proposals that would...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."